GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,712.50GBp
12:11pm EDT
Price Change (% chg)

28.50p (+1.69%)
Prev Close
1,684.00p
Open
1,681.50p
Day's High
1,712.50p
Day's Low
1,680.50p
Volume
5,967,343
Avg. Vol
6,703,631
52-wk High
1,816.00p
52-wk Low
1,314.00p

GSK.L

Chart for GSK.L

About

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in... (more)

Overall

Beta: 0.47
Market Cap (Mil.): £82,665.84
Shares Outstanding (Mil.): 4,908.90
Dividend: 18.00
Yield (%): 4.51

Financials

  GSK.L Industry Sector
P/E (TTM): 20.80 37.93 37.76
EPS (TTM): 0.81 -- --
ROI: 15.19 19.48 18.76
ROE: 59.84 20.17 19.59
Search Stocks

Drugmakers fear short-term 'turmoil' as China probes widen

LONDON/PARIS - Chinese authorities visited a regional office of French drugmaker Sanofi this week in the latest sign of a widening investigation into Western drugmakers.

9:30am EDT

RPT-INSIGHT-Corporate sleuths on edge after China detains foreign consultants

* Foreign couple's firm did work for GlaxoSmithKline, other drugmakers

31 Jul 2013

Insight: Corporate sleuths on edge after China detains foreign consultants

SHANGHAI - The detention by Chinese authorities of a British corporate investigator and his American wife in the wake of a corruption probe into pharmaceutical giant GlaxoSmithKline has had a chilling effect on other risk consultants working in China. | Video

31 Jul 2013

RPT-INSIGHT-Corporate sleuths on edge after China detains foreign consultants

* Foreign couple's firm did work for GlaxoSmithKline, other drugmakers

31 Jul 2013

INSIGHT-Corporate sleuths on edge after China detains foreign consultants

* Foreign couple's firm did work for GlaxoSmithKline, other drugmakers

31 Jul 2013

Analysis: Bayer immune to pharma's breakup bug?

FRANKFURT - Investors banking on Bayer to embrace a trend in the pharma sector to split off non-core units may be too far ahead of the curve.

29 Jul 2013

UPDATE 2-China state media says 18 more detained in GSK probe

BEIJING, July 27 - At least 18 more people have been detained in China in connection with a corruption scandal involving British drugmaker GlaxoSmithKline, state media reported, giving more details on an investigation that has rocked the company.

27 Jul 2013

China state media says 18 more detained in GSK probe

BEIJING - At least 18 more people have been detained in China in connection with a corruption scandal involving British drugmaker GlaxoSmithKline, state media reported, giving more details on an investigation that has rocked the company.

27 Jul 2013

China state media says 18 more detained in GSK probe

BEIJING - At least 18 more people have been detained in China in connection with a corruption scandal involving British drugmaker GlaxoSmithKline, state media reported, giving more details on a probe which has rocked the company.

26 Jul 2013

Why China pays too much for medicines

- China has a drug problem. While most Western countries spend 10-12 percent of their healthcare budget on medicines, in China it is well over 40 percent, a disparity that goes to the heart of Beijing's crackdown on the industry.

26 Jul 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$483.00
Provider: Plunkett Research, Ltd.
$99.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks